You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0088 Structural damage progression in patients treated with methotrexate, baricitinib monotherapy or baricitinib + methotrexate based on their level of clinical response in the phase 3 ra-begin study

Article metrics

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - prognosis, predictors and outcome
THU0088 Structural damage progression in patients treated with methotrexate, baricitinib monotherapy or baricitinib + methotrexate based on their level of clinical response in the phase 3 ra-begin study
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 20171102
Jul 20171201
Aug 20171000
Sep 20173603
Oct 20172803
Nov 20171901
Dec 20171000
Jan 20182406
Feb 20183605
Mar 20182603
Apr 20181401
May 2018800
Jun 20182400
Jul 20181000
Aug 2018601
Sep 2018802
Oct 2018400
Nov 20181205
Dec 2018401
Jan 20191000
Feb 2019001
Mar 2019206
Apr 2019202
May 2019202
Jun 2019201
Jul 20191005
Aug 20191004
Sep 2019001
Oct 2019702
Nov 2019402
Jan 2020801
Feb 2020602
Mar 2020202
Apr 2020200
May 2020003
Jun 2020801
Jul 2020804
Aug 2020202
Sep 20201000
Oct 2020401
Nov 20201805
Dec 2020801
Jan 2021201
Feb 2021002
Apr 20211006
Jun 2021002
Jul 2021004
Aug 2021104
Sep 2021007
Oct 20212021
Nov 20216013
Dec 2021605
Jan 2022205
Feb 2022201
Mar 2022805
Apr 2022604
May 20228010
Jun 20221402
Jul 2022601
Aug 20221205
Sep 2022207
Oct 2022604
Nov 2022401
Dec 2022400
Jan 20232001
Feb 2023201
Mar 20231604
May 2023204
Jul 2023204
Sep 2023203
Oct 2023200
Nov 2023001
Dec 20231000
Jan 2024502
Feb 2024200
Mar 2024402
Total5950214